MRS1754 (MRS-1754; MRS 1754) is a novel, selective and potent A2B antagonist 2B antagonist with anticancer activity. It inhibits the proliferation and migration of bladder urothelial carcinoma cells by modulating the MAPK (mitogen-activated protein kinase) pathway.

纯度：≥98%

CAS：264622-58-4